Inhibition of the human deacylase Sirtuin 5 by the indole GW5074.

[1]  Tobias Rumpf,et al.  Inhibitors of the NAD(+)-Dependent Protein Desuccinylase and Demalonylase Sirt5. , 2012, ACS medicinal chemistry letters.

[2]  C. Steegborn,et al.  Sirt5 Deacylation Activities Show Differential Sensitivities to Nicotinamide Inhibition , 2012, PloS one.

[3]  C. Olsen,et al.  Substrates for efficient fluorometric screening employing the NAD-dependent sirtuin 5 lysine deacylase (KDAC) enzyme. , 2012, Journal of medicinal chemistry.

[4]  M. Weyand,et al.  Structures, Substrates, and Regulators of Mammalian Sirtuins – Opportunities and Challenges for Drug Development , 2012, Front. Pharmacol..

[5]  L. Altucci,et al.  Sirtuins and Disease: The Road Ahead , 2012, Front. Pharmacol..

[6]  Johan Auwerx,et al.  Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase , 2011, Science.

[7]  Mahadevan Lakshminarasimhan,et al.  Emerging mitochondrial signaling mechanisms in physiology, aging processes, and as drug targets , 2011, Experimental Gerontology.

[8]  C. Steegborn,et al.  Function and regulation of the mitochondrial sirtuin isoform Sirt5 in Mammalia. , 2010, Biochimica et biophysica acta.

[9]  Y. Cen,et al.  Sirtuins inhibitors: the approach to affinity and selectivity. , 2010, Biochimica et biophysica acta.

[10]  A. Sauve.  Sirtuin chemical mechanisms. , 2010, Biochimica et biophysica acta.

[11]  Tobias Rumpf,et al.  Novel 3-arylideneindolin-2-ones as inhibitors of NAD+ -dependent histone deacetylases (sirtuins). , 2010, Journal of medicinal chemistry.

[12]  D. Sinclair,et al.  Mammalian sirtuins: biological insights and disease relevance. , 2010, Annual review of pathology.

[13]  Brian C. Smith,et al.  A continuous microplate assay for sirtuins and nicotinamide-producing enzymes. , 2009, Analytical biochemistry.

[14]  Takayoshi Suzuki,et al.  Identification of a cell-active non-peptide sirtuin inhibitor containing N-thioacetyl lysine. , 2009, Bioorganic & medicinal chemistry letters.

[15]  Matthew T. Walker,et al.  Novel Inhibitors Complexed with Glutamate Dehydrogenase , 2009, The Journal of Biological Chemistry.

[16]  Takashi Nakagawa,et al.  SIRT5 Deacetylates Carbamoyl Phosphate Synthetase 1 and Regulates the Urea Cycle , 2009, Cell.

[17]  M. Washburn,et al.  The SIRT2 deacetylase regulates autoacetylation of p300. , 2008, Molecular cell.

[18]  C. Steegborn,et al.  Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. , 2008, Journal of molecular biology.

[19]  Amy V. Lynch,et al.  Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes , 2007, Nature.

[20]  W. Sippl,et al.  Structure–Activity Studies on Suramin Analogues as Inhibitors of NAD+‐Dependent Histone Deacetylases (Sirtuins) , 2007, ChemMedChem.

[21]  David Sinclair,et al.  Sirtuins in mammals: insights into their biological function. , 2007, The Biochemical journal.

[22]  R. Sternglanz,et al.  Structural basis of inhibition of the human NAD+-dependent deacetylase SIRT5 by suramin. , 2007, Structure.

[23]  C. Kunick,et al.  Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition. , 2006, Journal of medicinal chemistry.

[24]  F. Alt,et al.  SIRT4 Inhibits Glutamate Dehydrogenase and Opposes the Effects of Calorie Restriction in Pancreatic β Cells , 2006, Cell.

[25]  P. Distefano,et al.  Inhibition of SIRT1 Catalytic Activity Increases p53 Acetylation but Does Not Alter Cell Survival following DNA Damage , 2006, Molecular and Cellular Biology.

[26]  P. Distefano,et al.  Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1. , 2005, Journal of medicinal chemistry.

[27]  S. Fields,et al.  Substrate-specific Activation of Sirtuins by Resveratrol* , 2005, Journal of Biological Chemistry.

[28]  L. Guarente,et al.  Calorie Restriction— the SIR2 Connection , 2005, Cell.

[29]  Phuong Chung,et al.  Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan , 2003, Nature.

[30]  V. Schramm,et al.  Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry. , 2003, Biochemistry.

[31]  P. A. Harris,et al.  The discovery of potent cRaf1 kinase inhibitors. , 2000, Bioorganic & medicinal chemistry letters.

[32]  U. Mahlknecht,et al.  Involvement of sirtuins in life-span and aging related diseases. , 2012, Advances in experimental medicine and biology.